These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18292189

  • 1. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
    Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G.
    Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189
    [Abstract] [Full Text] [Related]

  • 2. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T.
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [Abstract] [Full Text] [Related]

  • 3. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 4. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 5. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML, Widmer B, Dunger DB, Dalton RN.
    Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
    [Abstract] [Full Text] [Related]

  • 6. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
    Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T.
    Amino Acids; 2012 Aug; 43(2):805-11. PubMed ID: 22075968
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
    Lambden S, Tomlinson J, Piper S, Gordon AC, Leiper J.
    Crit Care; 2018 Dec 11; 22(1):336. PubMed ID: 30538005
    [Abstract] [Full Text] [Related]

  • 8. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May 11; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF.
    Med Hypotheses; 2004 May 11; 63(4):699-708. PubMed ID: 15325021
    [Abstract] [Full Text] [Related]

  • 10. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
    Bai Y, Hui R.
    Med Hypotheses; 2008 May 11; 70(5):962-6. PubMed ID: 17983707
    [Abstract] [Full Text] [Related]

  • 11. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun 11; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]

  • 12. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia.
    Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, Stehouwer CD, Rauwerda JA, van Leeuwen PA.
    Nephrol Dial Transplant; 2003 Dec 11; 18(12):2542-50. PubMed ID: 14605276
    [Abstract] [Full Text] [Related]

  • 13. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May 11; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

  • 14. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May 11; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 15. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats.
    Hsu CN, Huang LT, Lau YT, Lin CY, Tain YL.
    Transl Res; 2012 Feb 11; 159(2):90-8. PubMed ID: 22243793
    [Abstract] [Full Text] [Related]

  • 16. Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness.
    Ghashut RA, Blackwell S, Ryan S, Willox L, McMillan DC, Kinsella J, Talwar D.
    Eur J Clin Invest; 2017 Apr 11; 47(4):279-288. PubMed ID: 27930821
    [Abstract] [Full Text] [Related]

  • 17. The association of adipose-derived dimethylarginine dimethylaminohydrolase-2 with insulin sensitivity in experimental type 2 diabetes mellitus.
    Zheng J, Wang K, Jin P, Dong C, Yuan Q, Li Y, Yang Z.
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug 11; 45(8):641-8. PubMed ID: 23702602
    [Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
    Kanzelmeyer N, Tsikas D, Chobanyan-Jürgens K, Beckmann B, Vaske B, Illsinger S, Das AM, Lücke T.
    Amino Acids; 2012 May 11; 42(5):1765-72. PubMed ID: 21472412
    [Abstract] [Full Text] [Related]

  • 19. Asymmetric dimethylarginine and critical illness.
    Brinkmann SJ, de Boer MC, Buijs N, van Leeuwen PA.
    Curr Opin Clin Nutr Metab Care; 2014 Jan 11; 17(1):90-7. PubMed ID: 24281375
    [Abstract] [Full Text] [Related]

  • 20. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.
    Maas R, Tan-Andreesen J, Schwedhelm E, Schulze F, Böger RH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May 15; 851(1-2):220-8. PubMed ID: 17296339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.